NM

Nisha Malang

Active Director Director DIN 09632862
DIN 09632862 First appointment Jun 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value •••• Premium profile

About Nisha Malang

Data last updated:

Nisha Malang is a Director at N&N Pharma Private Limited (since 2022). The company operates in Pharma. N&N Pharma Private Limited reported revenue of ₹15.5 Lakh (FY 2025).

DIN 09632862
Primary Designation Director
Industry Pharma
First Appointment 09 Jun 2022
Oldest Company Age 4 yrs
Largest company N&N Pharma Private Limited · ₹15.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
N&N Pharma Private Limited U24290UP2022PTC165487
Director09 Jun 20222022₹15.5 Lakh (FY 2025)Active

Board colleagues of Nisha Malang

NameDINCompanyDesignation
Nikhil Malang09632861N&N Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
N&N Pharma Private Limited
Premium access

Shareholding and investment profile for Nisha Malang

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nisha Malang

Nisha Malang currently holds 1 directorship: N&N Pharma Private Limited (Director, since 09 Jun 2022, revenue ₹15.5 Lakh (FY 2025)).

Nisha Malang was first appointed on 09 Jun 2022 as Director at N&N Pharma Private Limited.

The current boards of Nisha Malang's companies include Nikhil Malang (N&N Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available